| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 3 | |
| #2 | Canada | 2 | |
| #3 | EPO (European Patent Office) | 2 | |
| #4 | United States | 2 | |
| #5 | Brazil | 1 | |
| #6 | China | 1 | |
| #7 | Colombia | 1 | |
| #8 | EAPO (Eurasian Patent Organization) | 1 | |
| #9 | Japan | 1 | |
| #10 | Republic of Korea | 1 | |
| #11 | Morocco | 1 | |
| #12 | Mexico | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Peptides |
| # | Name | Total Patents |
|---|---|---|
| #1 | Levetan Claresa S | 16 |
| #2 | Garsky Victor M | 7 |
| #3 | Upham Loraine V | 5 |
| #4 | Levetan Claresa | 1 |
| #5 | Victor M Garsky | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2009049222A1 | Compositions and methods of using the human proislet peptide receptor | |
| WO2008064306A2 | Methods and compositions relating to islet cell neogenesis | |
| US2009142338A1 | Methods and Compositions for Treating Type 1 and Type 2 Diabetes Mellitus and Related Conditions | |
| EP1858545A2 | Methods and pharmaceutical compositions for treating type 1 diabetes mellitus and other conditions |